griffithsin
grft
broadspectrum
antivir
protein
effect
sever
glycosyl
virus
evalu
vitro
vivo
antivir
activ
grft
japanes
enceph
viru
jev
infect
vitro
experi
show
treatment
jev
grft
inocul
cell
inhibit
infect
dosedepend
manner
inhibit
lgml
inhibitori
concentr
ic
ngml
nm
bind
assay
suggest
bind
grft
jev
virion
inhibit
jev
infect
vivo
experi
show
grft
mgkg
administ
intraperiton
viru
infect
could
complet
prevent
mortal
mice
challeng
intraperiton
lethal
dose
jev
studi
also
suggest
grft
prevent
jev
infect
entri
phase
target
viru
collect
data
demonstr
grft
antivir
agent
potenti
applic
develop
therapeut
jev
flaviviru
infect
japanes
enceph
viru
jev
mosquitoborn
viru
belong
genu
flaviviru
famili
flavivirida
jev
infect
caus
broad
spectrum
clinic
symptom
rang
asymptomat
infect
fever
enceph
even
death
enceph
caus
infect
estim
occur
case
approxim
encephalit
patient
die
survivor
develop
perman
neurolog
andor
psychiatr
sequela
jev
genom
singlestrand
positivesens
rna
encod
polyprotein
approxim
amino
acid
cleav
three
structur
protein
capsid
c
premembran
prm
envelop
glycoprotein
e
seven
nonstructur
protein
jev
envelop
glycoprotein
kda
contain
two
potenti
glycosyl
site
import
viru
attach
fusion
penetr
cell
tropism
virul
attenu
jev
prm
protein
also
contain
one
glycosyl
site
import
viru
releas
pathogenesi
griffithsin
grft
plantderiv
antivir
protein
isol
red
alga
griffithsia
sp
due
lectin
activ
grft
shown
broadspectrum
antivir
activ
sever
envelop
virus
includ
human
immunodefici
sarscov
hepat
c
viru
hcv
recombin
grft
produc
e
coli
nicotiana
benthamiana
express
system
alter
potent
antihiv
activ
safeti
profil
compar
nativ
grft
grft
dimer
lectin
six
princip
bind
site
bind
sarscov
spike
glycoprotein
prevent
viru
entri
target
cell
presenc
glycan
jev
virion
investig
whether
grft
display
antivir
activ
jev
infect
demonstr
grft
inhibit
jev
entri
host
cell
nanomolar
concentr
furthermor
show
inhibit
due
bind
abil
grft
glycan
jev
virion
final
show
grft
protect
balbc
mice
challeng
lethal
dose
jev
summari
data
establish
grft
antivir
agent
potenti
applic
develop
therapeut
jev
flaviviru
infect
babi
hamster
kidney
bhk
cell
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
contain
heatinactiv
fetal
calf
serum
fc
penicillin
uml
streptomycin
lgml
co
japanes
enceph
viru
jev
strain
genbank
access
propag
titrat
plaqu
assay
cell
balbc
mice
week
old
purchas
anim
center
nanj
armi
hospit
nanj
china
handl
accord
ethic
guidelin
nanj
agricultur
univers
china
lethal
dose
ld
jev
balbc
mice
determin
method
reed
munech
de
novo
synthesi
construct
express
purif
recombin
grft
five
pair
primer
design
tabl
base
grft
sequenc
genbank
id
synthes
grft
gene
de
novo
splice
overlap
extens
pcr
soepcr
method
fulllength
grft
pcr
product
bp
digest
ndei
xhoi
restrict
enzym
ligat
pcoldi
vector
takara
bio
inc
digest
enzym
construct
confirm
restrict
enzym
digest
dna
sequenc
analysi
ntermin
grft
express
purifi
dimer
describ
previous
minor
modif
briefli
e
coli
rosetta
cell
novagen
transform
pcoldigrft
plasmid
singl
coloni
use
inocul
ml
luriabertani
lb
medium
contain
ampicillin
lgml
cultur
grown
overnight
cultur
dilut
liter
lb
medium
contain
ampicillin
lgml
grown
valu
protein
express
induc
treat
cell
mm
isopropyl
bdthiogalactosid
iptg
h
cell
harvest
resuspend
bind
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
pmsf
cell
lyse
sonic
follow
centrifug
g
min
supernat
appli
immobil
metal
ion
affin
chromatographi
imac
column
biorad
grft
elut
elut
buffer
mm
sodium
phosphat
ph
mm
nacl
mm
imidazol
grft
purifi
gel
filtrat
chromatographi
use
superdex
tm
column
ge
healthcar
equilibr
pb
mm
na
hpo
mm
kh
po
mm
nacl
mm
kcl
endotoxin
grft
remov
use
detoxigel
endotoxin
remov
gel
graviti
flow
column
thermo
scientif
purifi
grft
character
sdspage
western
blot
analysi
concentr
grft
determin
bradford
assay
grft
store
use
product
antigrft
polyclon
antibodi
antijevediii
monoclon
antibodi
new
zealand
rabbit
inocul
subcutan
lg
grft
emulsifi
freund
complet
adjuv
sigmaaldrich
booster
dose
administ
week
lg
grft
emulsifi
freund
incomplet
adjuv
final
rabbit
serum
collect
week
western
blot
analysi
elisa
perform
evalu
immunoreact
grft
polyclon
antibodi
monoclon
antibodi
jev
envelop
glycoprotein
produc
immun
mice
purifi
jev
envelop
glycoprotein
domain
iii
express
e
coli
express
system
monoclon
antibodi
gener
describ
previous
produc
ascit
balbc
mice
inject
hybridoma
antibodi
purifi
protein
chromatographi
character
western
blot
analysi
elisa
cytotox
assay
cell
grown
plate
densiti
cellswel
incub
presenc
grft
lgml
h
cytotox
assess
measur
activ
lactat
dehydrogenas
ldh
cultur
medium
use
ldh
diagnost
kit
promega
accord
manufactur
instruct
analyz
regress
analysi
plaqu
assay
cell
densiti
cellswel
plate
incub
h
presenc
grftjev
mixtur
supernat
homogen
mous
brain
tissu
cell
wash
incub
dmem
contain
fc
mainten
medium
fortyeight
hour
later
cell
supernat
dilut
use
inocul
cell
densiti
cellswel
plate
hr
medium
remov
replac
agar
overlay
medium
contain
agar
fc
plate
incub
day
cell
stain
methylen
blue
observ
plaqu
format
inhibitori
concentr
ic
determin
antivir
activ
grft
assay
quantit
realtim
revers
transcript
pcr
qrtpcr
jev
genom
rna
extract
infect
cell
use
trizol
takara
use
synthes
cdna
revers
transcript
rt
util
primescript
rt
master
mix
perfect
real
time
kit
takara
realtim
pcr
perform
use
sybr
premix
ex
taq
tm
kit
takara
abi
prism
sequenc
detect
system
appli
biosystem
usa
data
analyz
ddct
approach
quantit
express
target
gene
normal
bactin
mrna
sampl
sequenc
primer
use
studi
list
tabl
measur
antivir
activ
grft
western
blot
analysi
jev
moi
premix
grft
lgml
h
cell
densiti
cellswel
incub
mixtur
h
cell
wash
incub
dmem
contain
fc
h
cell
wash
scrape
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
triton
mm
edta
sd
mm
sodium
orthovanad
mm
pmsf
contain
proteas
inhibitor
cocktail
roch
molecular
biochem
cell
lysat
clarifi
centrifug
rpm
min
protein
supernat
separ
sdspage
transfer
polyvinyliden
fluorid
pvdf
membran
millipor
block
incub
antijev
monoclon
antibodi
antibactin
monoclon
antibodi
sigmaaldrich
membran
incub
dilut
horseradishperoxidaseconjug
goat
antimous
igg
sigmaaldrich
immunoreact
band
visual
use
ecl
amersham
first
experi
pfu
jev
incub
medium
contain
grft
lgml
control
medium
grft
h
sampl
dilut
reduc
concentr
grft
tabl
list
primer
use
de
novo
synthesi
grft
splice
overlap
extens
pcr
soepcr
sequenc
forward
gtaatacatatgagcctgacccatcgcaagttcggtggtagtggtggaagtccgttcag
soepcr
primer
grft
synthesi
present
pair
forward
revers
restrict
enzym
sequenc
underlin
introduc
respect
ic
valu
remain
infect
determin
plaqu
assay
cell
virucid
concentr
vc
concentr
requir
inactiv
virion
calcul
second
experi
cell
incub
medium
contain
grft
lgml
control
medium
grft
h
wash
incub
viru
plaqu
assay
carri
assess
virucid
activ
grft
pulldown
assay
pulldown
assay
perform
accord
method
describ
previous
modif
histag
grft
lg
incub
imac
bead
novagen
ml
bind
buffer
mm
trishcl
ph
mm
nacl
h
bead
pellet
centrifug
g
min
pellet
bead
wash
three
time
remov
unbound
grft
wash
pellet
bead
resuspend
ml
wash
buffer
mm
trishcl
ph
mm
nacl
nonidet
centrifug
g
min
supernat
discard
viru
moi
incub
bead
h
bead
wash
three
time
wash
buffer
remov
unbound
virus
describ
bead
boil
sd
buffer
subject
western
blot
analysi
use
antijev
monoclon
antibodi
coimmunoprecipit
coip
assay
grft
lg
preincub
viru
moi
h
gentl
agit
time
protein
gsepharos
bead
pharmacia
wash
coip
buffer
mm
trishcl
ph
mm
nacl
triton
incub
rabbit
antigrft
polyclon
antibodi
pb
h
gentl
agit
jevgrft
mixtur
incub
pretreat
protein
gsepharos
bead
h
bead
wash
three
time
coip
buffer
resuspend
sd
buffer
boil
subject
western
blot
analysi
use
antijev
monoclon
antibodi
toxic
grft
first
evalu
balbc
mice
n
administ
mgkg
grft
intraperiton
ip
evalu
chang
weight
day
comparison
untreat
mice
vivo
efficaci
grft
jev
infect
evalu
balbc
mice
use
peripher
challeng
model
first
group
neg
control
n
inject
intraperiton
pb
follow
intracerebr
inject
steril
starch
h
later
second
group
grft
treat
n
first
inject
intraperiton
grft
mgkg
third
group
viru
control
n
first
inject
intraperiton
pb
h
later
second
third
group
challeng
ip
lethal
dose
ld
jev
follow
intracerebr
inject
starch
breach
bloodbrain
barrier
h
later
grfttreat
mice
level
grft
maintain
administ
two
dose
grft
mgkg
ip
daili
day
mice
examin
daili
develop
symptom
death
mice
sacrif
randomli
brain
collect
day
postinfect
neg
control
viru
control
grfttreat
mice
end
observ
grfttreat
mice
mous
brain
remov
asept
homogen
manual
steril
pb
ml
centrifug
g
min
supernat
harvest
filter
dilut
subject
western
blot
analysi
plaqu
assay
data
obtain
differ
experi
record
mean
standard
deviat
subject
oneway
analysi
varianc
anova
use
spss
data
analysi
softwar
version
spss
inc
chicago
il
usa
differ
mean
consid
signific
p
grft
gene
synthes
de
novo
use
soepcr
method
data
shown
grft
gene
ligat
express
vector
pcoldi
grft
express
purifi
e
coli
express
system
purifi
protein
analyz
sdspage
coomassi
blue
stain
western
blot
analysi
use
antihi
monoclon
antibodi
observ
dimer
grft
sdspage
western
blot
fig
b
consist
previou
report
investig
abil
grft
inhibit
jev
infect
cell
first
perform
plaqu
assay
result
reveal
incub
cell
premix
jevgrft
reduc
viru
infect
dosedepend
manner
fig
percentag
inhibit
p
p
lgml
lgml
grft
repres
inhibitori
concentr
ic
ngml
nm
fig
without
vitro
toxic
lgml
data
shown
treatment
jev
grft
inocul
cell
also
reduc
express
level
viral
envelop
protein
dosedepend
manner
fig
reveal
western
blot
analysi
use
antijev
envelop
protein
monoclon
antibodi
express
level
viral
envelop
protein
level
detect
jev
premix
lgml
grft
western
blot
signal
quantifi
use
imagej
softwar
plot
versu
grft
concentr
fig
result
indic
grft
could
significantli
prevent
jev
infect
cell
determin
whether
antijev
activ
grft
due
interact
viral
particl
previous
suggest
evalu
chang
jev
genom
rna
level
use
qrtpcr
found
viral
genom
rna
level
significantli
reduc
dosedepend
manner
reduct
lgml
grft
p
fig
cell
incub
presenc
premix
jevgrft
suggest
grft
could
interact
directli
viru
particl
therebi
reduc
infect
investig
whether
grft
inhibit
jev
infect
interact
cell
cell
incub
grft
h
viru
infect
result
show
preincub
cell
grft
signific
inhibitori
effect
jev
infect
fig
demonstr
grft
interact
receptor
requir
viru
entri
determin
grft
effect
infect
alreadi
establish
first
inocul
cell
viru
h
cell
wash
three
time
pb
incub
presenc
grft
hr
observ
chang
level
jev
genom
rna
hpi
fig
suggest
grft
act
earli
step
life
cycl
viru
final
ad
grft
simultan
jev
cell
investig
whether
grft
initi
antivir
activ
immedi
upon
contact
jev
shown
fig
grft
inhibit
jev
infect
cell
consist
immedi
effect
grft
infect
assess
effect
grft
viral
infect
virucid
assay
perform
result
reveal
grft
exhibit
concentrationdepend
virucid
activ
well
signific
inhibitori
effect
residu
infect
compar
control
fig
vc
ng
ml
valu
ic
suggest
grft
possess
potent
virucid
capac
convers
protect
observ
cell
first
treat
grft
wash
infect
viru
fig
result
indic
grft
act
virucid
similar
effect
infect
plaqu
assay
result
show
grft
exhibit
greater
inhibit
viru
infect
cell
infect
lower
moi
fig
convers
cell
infect
higher
moi
substanti
amount
viru
releas
even
grft
concentr
increas
high
lgml
western
blot
analysi
also
confirm
fig
therefor
efficaci
grft
invers
relat
multipl
infect
suggest
high
moi
reduc
antijev
activ
grft
reason
continu
supplement
grft
might
necessari
exert
antivir
activ
perform
pulldown
assay
demonstr
mechan
antijev
activ
grft
grft
bind
nlink
glycan
present
viru
glycoprotein
use
antijev
envelop
protein
antibodi
detect
interact
grft
jev
virion
jev
envelop
glycoprotein
kda
detect
presenc
grft
fig
furthermor
coimmunoprecipit
grftjev
complex
antigrft
polyclon
antibodi
conjug
prote
sepharos
bead
demonstr
jev
could
coimmunoprecipit
presenc
grft
absenc
grft
fig
data
suggest
antivir
activ
grft
jev
due
interact
viru
particl
vivo
evalu
antivir
activ
grft
jev
infect
grft
mgkg
administ
ip
balbc
mice
show
vivo
toxic
data
shown
thu
fig
shown
fig
grft
treatment
significantli
reduc
viru
titer
mous
brain
day
postinfect
g
brain
tissu
compar
viru
control
g
brain
tissu
agreement
observ
mice
treat
grft
also
reduc
viral
antigen
load
brain
tissu
reveal
western
blot
analysi
use
antijev
envelop
protein
antibodi
fig
viru
envelop
glycoprotein
detect
brain
tissu
surviv
mice
day
grfttreat
group
fig
result
show
treatment
grft
complet
protect
mice
challeng
lethal
dose
jev
report
grft
distinct
antivir
activ
sever
virus
antivir
activ
recombin
grft
similar
nativ
grft
therefor
studi
evalu
antivir
activ
recombin
grft
jev
infect
vitro
vivo
vitro
result
show
interact
grft
jev
virion
result
signific
inhibit
viru
infect
cell
nanomolar
concentr
monom
grft
contain
three
carbohydratebind
site
bind
nlink
glycan
viru
glycoprotein
grft
exist
domainswap
homodim
six
separ
bind
site
import
antivir
potenc
bind
grft
viru
glycoprotein
may
inhibit
conform
chang
requir
virustarget
cell
attach
subsequ
fusion
report
differ
antivir
activ
grft
sarscov
like
due
differ
bind
affin
grft
viral
envelop
glycoprotein
therefor
despit
grft
exert
antivir
activ
use
similar
mechan
mode
grft
interact
differ
viral
glycoprotein
main
factor
influenc
antivir
activ
grft
differ
virus
grft
administ
mgkg
jev
infect
could
provid
protect
mice
challeng
lethal
dose
jev
indic
abil
grft
satur
circul
jev
restrain
viru
infect
find
consist
observ
studi
sarscov
absenc
jev
protein
mice
day
postchalleng
indic
viru
clear
time
suggest
prophylact
valu
grft
jev
infect
vivo
studi
antivir
activ
grft
hcv
flaviviru
infect
demonstr
grft
delay
kinet
infect
inject
subcutan
mice
experi
observ
intraperiton
administr
grft
provid
surviv
advantag
mice
infect
lethal
dose
jev
shown
presenc
nglycan
hcv
restrict
antibodi
neutral
respons
protect
viru
recogn
anim
immun
system
one
studi
demonstr
grft
also
interact
glycan
expos
bind
site
increas
sensit
antibodi
conform
alter
caus
interact
grft
jev
glycoprotein
may
expos
hidden
epitop
jev
glycoprotein
allow
immun
system
becom
activ
involv
inhibit
jev
infect
addit
properti
grft
make
novel
antivir
agent
jev
infect
broadspectrum
antivir
activ
grft
taxonom
distinct
virus
due
abil
bind
broader
spectrum
oligosaccharid
antivir
lectin
cyanovirinn
cvn
scytovirin
svn
indiscrimin
activ
grft
repres
challeng
develop
grft
antivir
agent
howev
way
broadspectrum
antivir
activ
grft
may
advantag
exert
activ
threaten
virus
possess
glycosyl
envelop
protein
conclus
studi
demonstr
antivir
activ
grft
jev
infect
vitro
vivo
futur
work
pharmacokinet
grft
may
lead
develop
grft
antivir
agent
infect
jev
flavivirus
